Literature DB >> 18710762

Febrile urinary tract infections in children with an early negative voiding cystourethrogram after treatment of vesicoureteral reflux with dextranomer/hyaluronic acid.

Sherry Sedberry-Ross1, Dana C Rice, Hans G Pohl, A Barry Belman, Massoud Majd, H Gil Rushton.   

Abstract

PURPOSE: Children in whom nonsurgical management for vesicoureteral reflux fails are considered candidates for surgical intervention. An option is endoscopic treatment with Deflux(R). We reviewed our experience with febrile urinary tract infections in children following initial successful treatment of vesicoureteral reflux with Deflux and identified factors predictive of post-Deflux urinary tract infections. We also analyzed the incidence of delayed vesicoureteral reflux recurrence in these patients.
MATERIALS AND METHODS: We performed a retrospective chart review of all children from 2002 to 2006 diagnosed with grades I to IV vesicoureteral reflux who were treated with Deflux and who had a negative initial followup voiding cystourethrogram at 2 to 5 months. Patients were categorized into post-Deflux infection and infection-free groups. Predictive factors, including the number of preoperative febrile urinary tract infections, dysfunctional elimination and renal cortical defects on dimercapto-succinic acid scan, were analyzed and compared.
RESULTS: Of the patients 45 met all study inclusion and exclusion criteria. A total of 12 patients (27%) who were diagnosed with a culture documented febrile urinary tract infection were categorized into the infection group. Of 12 children in the post-Deflux infection group 11 (92%) had multiple predictors compared to 14 of 33 (42%) who remained infection-free (p = 0.005). Ten of these 12 patients (92%) were found to have evidence of vesicoureteral reflux when evaluated with voiding cystourethrogram/radionuclide cystogram after infection.
CONCLUSIONS: This study demonstrates that up to 27% of patients treated endoscopically may have a febrile urinary tract infection after an initial negative postoperative voiding cystourethrogram/radionuclide cystogram at 2 to 5 months and up to 92% of those will demonstrate delayed vesicoureteral reflux recurrence. Children with a history of 2 or more predictive factors, including multiple febrile urinary tract infections, dysfunctional elimination and/or renal cortical defects on dimercapto-succinic acid scan, may not be optimal candidates for Deflux. If endoscopic treatment is chosen, these patients require more vigilant followup, including late voiding cystourethrogram.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18710762     DOI: 10.1016/j.juro.2008.04.071

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  Medical versus surgical management for vesicoureteric reflux: the case for medical management.

Authors:  Armando J Lorenzo
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

2.  Rebuttal.

Authors:  Armando J Lorenzo
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

Review 3.  Vesicoureteral reflux--the role of bladder and bowel dysfunction.

Authors:  Jack S Elder; Mireya Diaz
Journal:  Nat Rev Urol       Date:  2013-10-15       Impact factor: 14.432

Review 4.  The impact of vesicoureteral reflux treatment on the incidence of urinary tract infection.

Authors:  George M Wadie; Kevin P Moriarty
Journal:  Pediatr Nephrol       Date:  2011-03-06       Impact factor: 3.714

Review 5.  Controversies in the management of vesicoureteral reflux: the rationale for the RIVUR study.

Authors:  Ranjiv Mathews; Myra Carpenter; Russell Chesney; Alejandro Hoberman; Ron Keren; Tej Mattoo; Marva Moxey-Mims; Lee Nyberg; Saul Greenfield
Journal:  J Pediatr Urol       Date:  2009-07-01       Impact factor: 1.830

6.  Clinical value of persistent but downgraded vesicoureteral reflux after dextranomer/hyaluronic acid injection in children.

Authors:  Minki Baek; Min Young Kang; Hahn-Ey Lee; Kwanjin Park; Hwang Choi
Journal:  J Korean Med Sci       Date:  2013-07-03       Impact factor: 2.153

7.  Endoscopic bulking materials for the treatment of vesicoureteral reflux: a review of our 20 years of experience and review of the literature.

Authors:  Boris Chertin; Stanislav Kocherov; Leonid Chertin; Alaeddin Natsheh; Amicur Farkas; Ofer Z Shenfeld; Sarel Halachmi
Journal:  Adv Urol       Date:  2011-04-06

8.  Patients with a history of infection and voiding dysfunction are at risk for recurrence after successful endoscopic treatment of vesico ureteral reflux and deserve long-term follow up.

Authors:  R Coletta; C Olivieri; V Briganti; M L Perrotta; L Oriolo; F Fabbri; A Calisti
Journal:  Urol Ann       Date:  2012-01

9.  Is a secondary procedure necessary in every case of failed endoscopic treatment for vesicoureteral reflux?

Authors:  Hyun Jin Jung; Young Jae Im; Yong Seung Lee; Myung Joo Kim; Sang Won Han
Journal:  Korean J Urol       Date:  2015-04-24

10.  Persistence and recurrence of vesicoureteric reflux in children after endoscopic therapy - implications of a risk-adapted follow-up.

Authors:  Bernhard Haid; Christoph Berger; Judith Roesch; Tanja Becker; Mark Koen; Werner Langsteger; Josef Oswald
Journal:  Cent European J Urol       Date:  2015-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.